Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 11OTHER 4OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 4Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Dexamethasone 4Cyclophosphamide 3pomalidomide 2pegylated granulocyte colony-stimulating factor 2pegfilgrastim 2carfilzomib 2Etoposide 2Cytarabine 2Bortezomib 2fosaprepitant 1fludarabine 1daratumumab 1Zoledronic Acid 1Vaccination 1Tropisetron 1Thiotepa 1Renal Replacement Therapy 1Prednisone 1Pneumococcal Vaccines 1Olanzapine 1Melphalan 1Lenalidomide 1Granulocyte Colony-Stimulating Factor 1Cyclosporine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Multiple Myeloma × Azacitidine × Clear all
NCT00412919 2013-12-16

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Bayside Health

Phase 2 Terminated
7 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡